Quick Answer
ACADIA PHARMACEUTICALS INC reported Total Revenue of $1.07 billion for fiscal year 2025.
ACADIA PHARMACEUTICALS INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.07B | +11.9% |
| 2024 | $957.80M | +31.8% |
| 2023 | $726.44M | +40.4% |
| 2022 | $517.24M | +6.8% |
| 2021 | $484.14M | +9.6% |
| 2020 | $441.75M | +30.3% |
| 2019 | $339.08M | +51.5% |
| 2018 | $223.81M | +79.2% |
| 2017 | $124.90M | +620.7% |
| 2016 | $17.33M | +28311.5% |
| 2015 | $61.0K | -49.2% |
| 2014 | $120.0K | -89.5% |
| 2013 | $1.15M | -76.7% |
| 2012 | $4.91M | +137.4% |
| 2011 | $2.07M | -95.1% |
| 2010 | $42.13M | +558.5% |
| 2009 | $6.40M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $278.63M | +11.3% | +5.3% |
| June 30, 2025 | $264.57M | +9.3% | +8.3% |
| March 31, 2025 | $244.32M | +18.7% | -2.4% |
| September 30, 2024 | $250.40M | +18.3% | +3.5% |
| June 30, 2024 | $241.96M | +46.4% | +17.6% |
| March 31, 2024 | $205.83M | +73.8% | -2.8% |
| September 30, 2023 | $211.70M | +62.0% | +28.1% |
| June 30, 2023 | $165.24M | +22.8% | +39.5% |
- ACADIA PHARMACEUTICALS INC showed an increase of +11.9% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, ACADIA PHARMACEUTICALS INC’s total revenue has grown by 16644.9% (from $6.40 million to $1.07 billion).
- The most recent figure is from ACADIA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: